English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novo Nordisk Inc.
Carol Ostrow
| Nov 17, 2017
Diabetes 360 survey shows patient desire for more holistic care
Carol Ostrow
| Nov 16, 2017
European study demonstrates economic benefits of Tresiba
Carrie Bradon
| Sep 18, 2017
Novo Nordisk offers aid, collects donations for those affected by Harvey
Robert Hadley
| Jun 20, 2017
Novo Nordisk’s Xultophy better for diabetics than insulin alone, study says
Cheyenne Dickerson
| May 14, 2017
Obese adults begin to manage weight after life-changing medical event, study shows
Caitlin Nordahl
| Apr 24, 2017
Novo Nordisk expands HemaGo for easy sharing of hemophilia treatment information
Ruth de Jauregui
| Apr 14, 2017
FDA panel reviews license application for potential hemophilia B treatment
Gene Johnson
| Mar 25, 2017
CVS Health to launch a new prescription savings program
Trending
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’